# Efficacy Study to Evaluate Antimicrobial Effectiveness of ZuraPrep™ (ZX-ZP-0055)

> **NCT02296645** · PHASE2 · COMPLETED · sponsor: **Zurex Pharma, Inc.** · enrollment: 36 (actual)

## Conditions studied

- Surgical Site Infection

## Interventions

- **DRUG:** ZuraPrep
- **DRUG:** ChloraPrep

## Key facts

- **NCT ID:** NCT02296645
- **Lead sponsor:** Zurex Pharma, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-11
- **Primary completion:** 2015-01
- **Final completion:** 2015-01
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2016-07-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02296645

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02296645, "Efficacy Study to Evaluate Antimicrobial Effectiveness of ZuraPrep™ (ZX-ZP-0055)". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT02296645. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*